Search

Your search keyword '"Gingras, Anne-Claude"' showing total 1,497 results

Search Constraints

Start Over You searched for: Author "Gingras, Anne-Claude" Remove constraint Author: "Gingras, Anne-Claude"
1,497 results on '"Gingras, Anne-Claude"'

Search Results

1. Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability

2. FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation

5. Kindlin2 enables EphB/ephrinB bi-directional signaling to support vascular development

6. Pervasive mislocalization of pathogenic coding variants underlying human disorders

10. A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study

12. The TSC22D, WNK, and NRBP gene families exhibit functional buffering and evolved with Metazoa for cell volume regulation

14. Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease

16. Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring

17. Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity

19. The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch

22. Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV

23. Genome screening, reporting, and genetic counseling for healthy populations

26. Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity

27. COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series

28. A central chaperone-like role for 14-3-3 proteins in human cells

33. The bromodomain-containing protein Ibd1 links multiple chromatin related protein complexes to highly expressed genes in Tetrahymena thermophila

35. Voices in methods development.

36. Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens

37. Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection

42. Extracellular proximal interaction profiling by cell surface–targeted TurboID reveals LDLR as a partner of liganded EGFR.

43. Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters.

44. Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study.

45. Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study.

47. mRNA Vaccine-Induced SARS-CoV-2 Spike-Specific IFN-γ and IL-2 T-cell Responses are Predictive of Serological Neutralization and are Transiently Enhanced by Pre-Existing Cross-Reactive Immunity

48. 155 SARS-CoV-2 Breakthrough Infection Increases the Adaptive Immune Responses of Vaccinated Immunosuppressed Children

49. A bivalent COVID-19 mRNA vaccine, PTX-COVID19-M1.2, elicited broad immune responses and protected animals from SARS-CoV-2 Omicron subvariants infection

50. Mapping the global interactome of the ARF family reveals spatial organization in cellular signaling pathways

Catalog

Books, media, physical & digital resources